Published in J Hypertens on December 01, 1999
Leptin mediates the increase in blood pressure associated with obesity. Cell (2014) 3.09
Cardiac remodeling in obesity. Physiol Rev (2008) 2.95
Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem (2010) 2.53
Mouse models of the metabolic syndrome. Dis Model Mech (2010) 1.55
Rodent models for metabolic syndrome research. J Biomed Biotechnol (2010) 1.53
Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res (2015) 1.45
Cardiovascular and autonomic phenotype of db/db diabetic mice. Exp Physiol (2009) 1.23
Selective leptin resistance revisited. Am J Physiol Regul Integr Comp Physiol (2013) 1.21
Mechanisms mediating renal sympathetic activation to leptin in obesity. Am J Physiol Regul Integr Comp Physiol (2008) 1.20
Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes. Curr Diabetes Rev (2014) 1.12
A functional melanocortin system may be required for chronic CNS-mediated antidiabetic and cardiovascular actions of leptin. Diabetes (2009) 1.10
Genetic background determines response to hemostasis and thrombosis. BMC Blood Disord (2006) 1.05
Overweight, physical activity and high blood pressure in children: a review of the literature. Vasc Health Risk Manag (2007) 1.00
Role of vascular extracellular superoxide dismutase in hypertension. Hypertension (2011) 0.98
Differential effects of insulin on sympathetic nerve activity in agouti obese mice. J Hypertens (2010) 0.98
The role of obesity in the pathogenesis of hypertension. Nat Clin Pract Nephrol (2008) 0.96
Role of leptin in atherogenesis. Exp Clin Cardiol (2006) 0.94
Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol (2011) 0.93
Neuroendocrine circuits governing energy balance and stress regulation: functional overlap and therapeutic implications. Cell Metab (2014) 0.92
Intact renal afferent arteriolar autoregulatory responsiveness in db/db mice. Am J Physiol Renal Physiol (2008) 0.91
Diabetes and cardiovascular autonomic dysfunction: application of animal models. Auton Neurosci (2008) 0.90
Control of metabolic and cardiovascular function by the leptin-brain melanocortin pathway. IUBMB Life (2013) 0.90
Characterization of a new animal model of metabolic syndrome: the DahlS.Z-Lepr(fa)/Lepr(fa) rat. Nutr Diabetes (2011) 0.89
Neuroimmune communication in hypertension and obesity: a new therapeutic angle? Pharmacol Ther (2013) 0.85
Role of Shp2 in forebrain neurons in regulating metabolic and cardiovascular functions and responses to leptin. Int J Obes (Lond) (2013) 0.85
Obesity hypertension: the regulatory role of leptin. Int J Hypertens (2011) 0.83
Cardiovascular changes in animal models of metabolic syndrome. J Diabetes Res (2013) 0.83
Control of respiratory and cardiovascular functions by leptin. Life Sci (2015) 0.83
PI3K signaling: A key pathway in the control of sympathetic traffic and arterial pressure by leptin. Mol Metab (2013) 0.82
The sympathetic nervous system in obesity hypertension. Curr Hypertens Rep (2013) 0.80
Adipocyte-derived factor reduces vasodilatory capability in ob-/ob- mice. Am J Physiol Heart Circ Physiol (2009) 0.80
Renal hemodynamic and morphological changes after 7 and 28 days of leptin treatment: the participation of angiotensin II via the AT1 receptor. PLoS One (2015) 0.79
Plastic alteration of vestibulo-cardiovascular reflex induced by 2 weeks of 3-G load in conscious rats. Exp Brain Res (2007) 0.79
Na+-sensitive elevation in blood pressure is ENaC independent in diet-induced obesity and insulin resistance. Am J Physiol Renal Physiol (2016) 0.79
Approach to assessing determinants of glucose homeostasis in the conscious mouse. Mamm Genome (2014) 0.79
Resistin, an Adipokine with Non-Generalized Actions on Sympathetic Nerve Activity. Front Physiol (2015) 0.78
Leptin expression affects metabolic rate in zebrafish embryos (D. rerio). Front Physiol (2013) 0.78
Leptin and the Regulation of Renal Sodium Handling and Renal Na-Transporting ATPases: Role in the Pathogenesis of Arterial Hypertension. Curr Cardiol Rev (2010) 0.78
Leptin Induces Hypertension and Endothelial Dysfunction via Aldosterone-Dependent Mechanisms in Obese Female Mice. Hypertension (2016) 0.78
Lean heart: Role of leptin in cardiac hypertrophy and metabolism. World J Cardiol (2015) 0.76
Central Administration of Insulin and Leptin Together Enhance Renal Sympathetic Nerve Activity and Fos Production in the Arcuate Nucleus. Front Physiol (2017) 0.75
The Leptin Receptor Complex: Heavier Than Expected? Front Endocrinol (Lausanne) (2017) 0.75
Animal models of metabolic syndrome: a review. Nutr Metab (Lond) (2016) 0.75
Leptin beyond the lipostat: key component of blood pressure regulation. Circ Res (2015) 0.75
Investigating the Metabolic Syndrome: Contributions of Swine Models. Toxicol Pathol (2016) 0.75
Leptin as a Mediator of Obesity-Induced Hypertension. Curr Obes Rep (2016) 0.75
The Role of the Autonomic Nervous System in the Pathophysiology of Obesity. Front Physiol (2017) 0.75
Molecular Mechanisms of Sodium-Sensitive Hypertension in the Metabolic Syndrome. Curr Hypertens Rep (2017) 0.75
Selective in vitro growth of T lymphocytes from normal human bone marrows. Science (1976) 15.73
Functional and morphologic characterization of human T cells continuously grown in vitro. J Immunol (1977) 6.30
Comparison of wet combing with malathion for treatment of head lice in the UK: a pragmatic randomised controlled trial. Lancet (2000) 6.00
Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli. Nucleic Acids Res (1984) 3.94
Antibiotic resistance mutations in ribosomal RNA genes of Escherichia coli. Methods Enzymol (1988) 3.60
Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am J Physiol (1981) 3.18
Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest (1997) 2.98
The effect of foot structure and range of motion on musculoskeletal overuse injuries. Am J Sports Med (1999) 2.97
Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg (1989) 2.84
Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation (2000) 2.83
Nonsense codons in human beta-globin mRNA result in the production of mRNA degradation products. Mol Cell Biol (1992) 2.51
The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin Sci (Lond) (1993) 2.18
Differential expression of angiotensin receptor 1A and 1B in mouse. Am J Physiol (1994) 1.91
RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int (2006) 1.88
Screening for human immunodeficiency virus: a survey of British clinical pharmacology units. Br J Clin Pharmacol (1993) 1.85
Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension (1999) 1.82
The kidney androgen-regulated protein promoter confers renal proximal tubule cell-specific and highly androgen-responsive expression on the human angiotensinogen gene in transgenic mice. J Biol Chem (1997) 1.78
Erythromycin resistance due to a mutation in a ribosomal RNA operon of Escherichia coli. Proc Natl Acad Sci U S A (1982) 1.73
The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circ Res (1998) 1.73
Critical roles of a cyclic AMP responsive element and an E-box in regulation of mouse renin gene expression. J Biol Chem (2001) 1.72
Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens (1999) 1.62
Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice. Physiol Genomics (1999) 1.60
L-NMMA increases blood pressure in man. Lancet (1993) 1.60
Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest (2000) 1.59
Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest (1996) 1.59
Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans. Clin Sci (Lond) (2001) 1.59
Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am J Physiol (1998) 1.57
Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel. AIDS (2000) 1.53
Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ Res (2001) 1.50
Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion. Ann Intern Med (1999) 1.48
Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation (1999) 1.44
Epidemiological patterns of musculoskeletal injuries and physical training. Med Sci Sports Exerc (1999) 1.43
The prediction of local or regional recurrence after simple mastectomy for operable breast cancer. Br J Surg (1985) 1.42
Effects of leptin on insulin sensitivity in normal rats. Endocrinology (1997) 1.42
Prophylactic cranial irradiation for small-cell lung cancer: long-term results. Clin Oncol (R Coll Radiol) (1989) 1.39
Stress fracture in military recruits: gender differences in muscle and bone susceptibility factors. Bone (2000) 1.37
Differential requirement for SLP-76 domains in T cell development and function. Immunity (2001) 1.36
The role of biologically effective dose (BED) in clinical oncology. Clin Oncol (R Coll Radiol) (2001) 1.35
Shared care: a review of the literature. Fam Pract (1996) 1.34
Sympathetic and cardiorenal actions of leptin. Hypertension (1997) 1.32
Use of anorectal manometry during rectal infusion of saline to investigate sphincter function in incontinent patients. Gastroenterology (1983) 1.31
Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes. J Clin Invest (1997) 1.29
Ano-rectal activity in man during rectal infusion of saline: a dynamic assessment of the anal continence mechanism. J Physiol (1982) 1.29
Efficient liver-specific deletion of a floxed human angiotensinogen transgene by adenoviral delivery of Cre recombinase in vivo. J Biol Chem (1999) 1.28
Retinoic acid-mediated activation of the mouse renin enhancer. J Biol Chem (2000) 1.25
ABC of breast diseases. Management of regional nodes in breast cancer. BMJ (1994) 1.23
Role of proximal promoter elements in regulation of renin gene transcription. J Biol Chem (1996) 1.22
Elevated blood pressure in transgenic mice with brain-specific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoter. Circ Res (2001) 1.22
Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem (1994) 1.22
Androgen-dependent regulation of human angiotensinogen expression in KAP-hAGT transgenic mice. Am J Physiol Renal Physiol (2001) 1.19
ABC of breast diseases. Breast cancer. BMJ (1994) 1.17
Dual-energy X-ray absorptiometry derived structural geometry for stress fracture prediction in male U.S. Marine Corps recruits. J Bone Miner Res (1996) 1.13
Gene transfer of endothelial nitric oxide synthase (eNOS) in eNOS-deficient mice. Am J Physiol (1999) 1.12
Spectinomycin resistance due to a mutation in an rRNA operon of Escherichia coli. J Bacteriol (1983) 1.11
Identification of three human renin mRNA isoforms from alternative tissue-specific transcriptional initiation. Physiol Genomics (2000) 1.11
Cytokine mRNA expression in human platelets and a megakaryocytic cell line and cytokine modulation of platelet function. Cytokine (1997) 1.09
The early results from a randomised study of radiotherapy versus Nolvadex (tamoxifen) as initial treatment for stage III breast cancer. Eur J Surg Oncol (1988) 1.09
Highly regulated cell type-restricted expression of human renin in mice containing 140- or 160-kilobase pair P1 phage artificial chromosome transgenes. J Biol Chem (1999) 1.09
Intracerebroventricular insulin produces nonuniform regional increases in sympathetic nerve activity. Am J Physiol (1994) 1.09
Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy. Eur J Cancer Clin Oncol (1989) 1.08
Gender differences in musculoskeletal injury rates: a function of symptom reporting? Med Sci Sports Exerc (1999) 1.08
Identification of cis elements in the cardiac troponin T gene conferring specific expression in cardiac muscle of transgenic mice. Circ Res (2000) 1.08
Asymptomatic sexually transmitted disease prevalence in four military populations: application of DNA amplification assays for Chlamydia and gonorrhea screening. J Infect Dis (1998) 1.07
Appropriate tissue- and cell-specific expression of a single copy human angiotensinogen transgene specifically targeted upstream of the HPRT locus by homologous recombination. J Biol Chem (2000) 1.05
Munc18c regulates insulin-stimulated glut4 translocation to the transverse tubules in skeletal muscle. J Biol Chem (2000) 1.04
131I and 111In-labelled monoclonal antibody imaging of primary lung carcinoma. Nucl Med Commun (1986) 1.03
Distribution of vasodilator nerves in the canine hindlimb. Am J Physiol (1970) 1.01
Transgenic mice expressing an intracellular fluorescent fusion of angiotensin II demonstrate renal thrombotic microangiopathy and elevated blood pressure. Am J Physiol Heart Circ Physiol (2010) 1.01
Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity. Am J Physiol (1986) 1.01
Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo. Circulation (1998) 0.99
Transactivation of the human renin promoter by the cyclic AMP/protein kinase A pathway is mediated by both cAMP-responsive element binding protein-1 (CREB)-dependent and CREB-independent mechanisms in Calu-6 cells. J Biol Chem (1997) 0.99
Successful replication of parvovirus B19 in the human megakaryocytic leukemia cell line MB-02. J Virol (1993) 0.98
Differential control of adrenal and renal sympathetic nerve activity during hemorrhagic hypotension in rats. Circ Res (1989) 0.98
State-of-the-art-lecture: Obesity-induced hypertension: new concepts from the emerging biology of obesity. Hypertension (1999) 0.98
The angiotensinogen gene is expressed in both astrocytes and neurons in murine central nervous system. Brain Res (1999) 0.98
Parotid metastases from carcinoma of the breast. Clin Radiol (1989) 0.97
Expression of murine renin genes during fetal development. Mol Endocrinol (1990) 0.97
NF-Y antagonizes renin enhancer function by blocking stimulatory transcription factors. Hypertension (2001) 0.97
Frequency response characteristics of sympathetically mediated vasomotor waves in humans. Am J Physiol (1998) 0.97
Vectors for high-level expression of cDNAs controlled by tissue-specific promoters in transgenic mice. Biotechniques (2001) 0.96
Modulation of homeobox gene expression alters the phenotype of human hematopoietic cell lines. EMBO J (1992) 0.96
Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation (1996) 0.95
Macrophage-specific expression of human lipoprotein lipase accelerates atherosclerosis in transgenic apolipoprotein e knockout mice but not in C57BL/6 mice. Arterioscler Thromb Vasc Biol (2001) 0.95
Species-specific differences in positive and negative regulatory elements in the renin gene enhancer. Circ Res (1999) 0.94
Neurogenic and humoral factors controlling vascular resistance in the spontaneously hypertensive rat. Circ Res (1974) 0.94
Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen. Stroke (2000) 0.93
Bacterial contamination rates during bone allograft retrieval. J Arthroplasty (1999) 0.93
Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction. Kidney Int (1998) 0.93
Endothelial prostaglandin secretion: effects of typhus rickettsiae. J Infect Dis (1990) 0.93
ABC of breast diseases: breast cancer. BMJ (2000) 0.93
Role of corticotrophin-releasing factor in effects of leptin on sympathetic nerve activity and arterial pressure. Hypertension (2001) 0.93
The effects of short-term passive smoke exposure on endothelium-dependent and independent vasodilation. J Hypertens (1999) 0.93
Modulation of baroreflex sensitivity and spectral power of blood pressure by heat stress and aging. Am J Physiol (1997) 0.92
A prospective study of the effect of haemorrhoidectomy on sphincter function and faecal continence. Br J Surg (1982) 0.92
Differences in anorectal manometry between patients with haemorrhoids and patients with descending perineum syndrome: implications for management. Br J Surg (1983) 0.92
Conserved enhancer elements in human and mouse renin genes have different transcriptional effects in As4.1 cells. Circ Res (1997) 0.92